619 Pharmacologic modulation of tumor glycolysis to improve responses to immune checkpoint blockade therapy

619 Pharmacologic modulation of tumor glycolysis to improve responses to immune checkpoint blockade therapy

Bibliographic Details
Main Authors:	Taha Merghoub, Sadna Budhu, Roberta Zappasodi, Levi Mangarin, Svena Verma, Inna Serganova, Rachana Maniyar, Ronald Blasberg, Myat Ko
Format:	Article
Language:	English
Published:	BMJ Publishing Group 2021-11-01
Series:	Journal for ImmunoTherapy of Cancer

Similar Items

1444 Pharmacologic LDH inhibition redirects intratumoral glucose consumption and improves response to CTLA-4 blockade
by: Jedd D Wolchok, et al.
Published: (2023-11-01)

254 CTLA-4 blockade promotes Treg glucose metabolism and reduces Treg functional stability in glycolysis-defective tumors
by: Yasin Senbabaoglu, et al.
Published: (2020-11-01)

525 Investigating dynamic IDO-Kyn-AhR pathway-induced tumor immunosuppression using imaging modality to optimize AhR therapeutic intervention
by: Jedd D Wolchok, et al.
Published: (2023-11-01)

Facts and Perspectives: Implications of tumor glycolysis on immunotherapy response in triple negative breast cancer
by: Ashley Schreier, et al.
Published: (2023-01-01)

Blockade of the AHR restricts a Treg-macrophage suppressive axis induced by L-Kynurenine
by: Luis Felipe Campesato, et al.
Published: (2020-08-01)

Increased p53 expression induced by APR-246 reprograms tumor-associated macrophages to augment immune checkpoint blockade
by: Arnab Ghosh, et al.
Published: (2022-09-01)

549 Characterizing double positive T cells in the tumor microenvironment: a tale of promiscuous cell fates
by: Xia Yang, et al.
Published: (2020-11-01)

Cyclophosphamide enhances the antitumor potency of GITR engagement by increasing oligoclonal cytotoxic T cell fitness
by: Daniel Hirschhorn, et al.
Published: (2021-10-01)

493 Tired and hungry: a potential role for CD47 in T cell exhaustion
by: Taha Merghoub, et al.
Published: (2020-11-01)

968 PD-1hiFoxp3-CD4+ tumor-infiltrating T-cell lineage commitment impacts the immunotherapy outcome
by: Jedd D Wolchok, et al.
Published: (2023-11-01)

604 Combining a novel dual RAF/MEK inhibitor with immunomodulation to promote an anti-tumor response
by: Taha Merghoub, et al.
Published: (2021-11-01)

Editorial: Dynamic Biomarkers of Response to Anti-Immune Checkpoint Inhibitors in Cancer
by: Said Dermime, et al.
Published: (2021-10-01)

Editorial: Factors determining long term anti-tumor responses to immune checkpoint blockade therapy
by: Roberta Zappasodi, et al.
Published: (2022-12-01)

Enhancement of PSMA-Directed CAR Adoptive Immunotherapy by PD-1/PD-L1 Blockade
by: Inna Serganova, et al.
Published: (2017-03-01)

Epigenetic, Metabolic, and Immune Crosstalk in Germinal-Center-Derived B-Cell Lymphomas: Unveiling New Vulnerabilities for Rational Combination Therapies
by: Inna Serganova, et al.
Published: (2022-01-01)

Preoperative immune checkpoint inhibition and cryoablation in early-stage breast cancer
by: Elizabeth Comen, et al.
Published: (2024-02-01)

ATP-Binding Cassette Transporters Modulate Both Coelenterazine- and D-Luciferin-Based Bioluminescence Imaging
by: Ruimin Huang, et al.
Published: (2011-05-01)

AGW 619 - CORPORATE FINANCE APRIL 08.
by: PPP, Pusat Pengajian Pengurusan
Published: (2008)

AGW 619 - Corporate Finance - February 2000
by: PPP, Pusat Pengajian Pengurusan
Published: (2000)

Non-invasive molecular imaging and reporter genes
by: Serganova Inna, et al.
Published: (2006-03-01)

Inhibition of glycolysis-driven immunosuppression with a nano-assembly enhances response to immune checkpoint blockade therapy in triple negative breast cancer
by: Xijiao Ren, et al.
Published: (2023-11-01)

Pharmacological Activation of Estrogen Receptor Beta Overcomes Tumor Resistance to Immune Checkpoint Blockade Therapy
by: Shuang Huang, et al.
Published: (2020-09-01)

Genetic and Drug Inhibition of LDH-A: Effects on Murine Gliomas
by: Masatomo Maeda, et al.
Published: (2022-05-01)

AGW606-619 - CORPORATE FINANCE - FEBRUARI 1998.
by: PPP, Pusat Pengajian Pengurusan
Published: (1998)

MCT4 blockade increases the efficacy of immune checkpoint blockade
by: Christian Schmidl, et al.
Published: (2023-10-01)

Cytotoxic T Lymphocytes Control Growth of B16 Tumor Cells in Collagen–Fibrin Gels by Cytolytic and Non-Lytic Mechanisms
by: Barun Majumder, et al.
Published: (2023-06-01)

Immune-Checkpoint Blockade Therapy in Lymphoma
by: Ayumi Kuzume, et al.
Published: (2020-07-01)

Egypt under the Sasanians (619-29): "stability, continuity, and tolerance"?
by: Booth, P
Published: (2022)

شعر الرشید النابلسي ت ٦١٩ ھ جمع وتحقیق
by: أ.م.د.عاصم عبد دواح شبیب الدلیمي
Published: (2019-02-01)

Dual Reporter Gene Imaging
by: Jiantu Che, et al.
Published: (2005-04-01)

Metabolomic adaptations and correlates of survival to immune checkpoint blockade
by: Haoxin Li, et al.
Published: (2019-09-01)

LDH-A—Modulation and the Variability of LDH Isoenzyme Profiles in Murine Gliomas: A Link with Metabolic and Growth Responses
by: Masahiro Shindo, et al.
Published: (2022-05-01)

789 Immune checkpoint blockade augments cyclophosphamide induced anti-tumor immunity by expanding effector CD8+ T cell clones in a preclinical melanoma model
by: Alan N Houghton, et al.
Published: (2023-11-01)

Increased tumor glycolysis is associated with decreased immune infiltration across human solid tumors
by: Ivan J. Cohen, et al.
Published: (2022-11-01)

ORGN 619-Organocatalytic approach to tetrahydrofurans: Application to the total synthesis of (-)-Goniothalesdiol
by: Silva, F, et al.
Published: (2007)

Targeting Phosphatidylserine Enhances the Anti-tumor Response to Tumor-Directed Radiation Therapy in a Preclinical Model of Melanoma
by: Sadna Budhu, et al.
Published: (2021-01-01)

CANCER IMMUNOTHERAPY BASED ON THE BLOCKADE OF IMMUNE CHECKPOINTS
by: A. V. Bogolyubova, et al.
Published: (2015-10-01)

Immune Checkpoint Blockade for Aspergillosis and Mucormycosis Coinfection
by: Jan Christoph Banck, et al.
Published: (2021-03-01)

Acquired Resistance to Immune Checkpoint Blockade Therapies
by: Xianda Zhao, et al.
Published: (2020-05-01)

Immune-Checkpoint Blockade and Active Immunotherapy for Glioma
by: Brian J. Ahn, et al.
Published: (2013-11-01)